Company Search:
Advanced Search
Sponsored Links
CanniMed Therapeutics Inc Company Snapshot
CanniMed Therapeutics Inc operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares CanniMed Therapeutics Inc with three other pharmaceutical manufacturers in North America: Enzon Pharmaceuticals, Inc. of the United States (2016 sales of $8.38 million ), Golden Leaf Holdings Ltd (10.12 million Canadian Dollars [US$8.14 million] ), and Curis, Inc. which is based in the United States ($7.53 million of which 100% was Therapeutic Drug Dev).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
CanniMed Therapeutics Inc
  Stock Performance Chart for CanniMed Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 24.03
(Figures in Canadian Dollars)
1 Week -10.8%   13 Weeks 23.8%  
4 Weeks 107.3%   52 Weeks 116.7%  
CanniMed Therapeutics Inc Key Data:
  Ticker: CMED Country: Canada
  Exchanges: TOR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 9,797,000
(Year Ending Jan 2017).
Employees: N/A
  Currency: Canadian Dollars Market Cap: 587,134,890
  Fiscal Yr Ends: October Shares Outstanding: 24,433,412
  Share Type: Common Closely Held Shares: 7,441,906
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.